Step 1 of 2
CAR T-cell therapy is an established treatment option for patients with R/R B-cell lymphomas, but successful use requires timely referral, coordinated care, and proactive management of treatment-related toxicities. This slideset reviews current evidence and practical considerations for CAR T-cell therapy, including patient referral and preparation, treatment logistics, and strategies for recognizing and managing acute and late adverse events.